sacituzumab govitecan
gilead sciences
['mbc', 'sacituzumab govitecan']
sacituzumab govitecan in hr+/her2- mbc... not really convincing. #asco22 
Hematology/Oncology fellow @EinsteinMed @MontefioreNYC via @slusom and @USJLiban. Interested in EBM & clinical reasoning. Views are my own.